Can Hydrogen Water Enhance Oxygen Saturation in Patients with Chronic Lung Disease? A Non-Randomized, Observational Pilot Study.
Ram B Singh, Alex Tarnava, Ghizal Fatima, Jan Fedacko, Viliam Mojto, Tyler W LeBaron · Diseases (Basel, Switzerland) · 2023
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 10 patients with chronic lung diseases due to COPD (n = 7), however, vitamin E, vitamin C, and nitrite levels showed a significant increase after 4 week of hydrogen administration. These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence oxidative-stress regulation.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in 10 patients with chronic lung diseases due to COPD (n = 7). However, vitamin E, vitamin C, and nitrite levels showed a significant increase after 4 week of hydrogen administration.
What the Researchers Studied
The researchers studied 10 patients with chronic lung diseases due to COPD (n = 7). The study used a human clinical study.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 8 mM H₂ (≈16.1 mg/L); reported treatment duration: 4 weeks. However, vitamin E, vitamin C, and nitrite levels showed a significant increase after 4 week of hydrogen administration. The authors concluded that treatment with HRW in patients with hypoxia from chronic lung diseases may decrease oxidative stress and improve oxygen saturation in some patients. Molecular hydrogen represents a novel antioxidant that can help prevent oxidative stress [ 5, 8 ]. These results indicate that administration of molecular hydrogen may help reduce oxidative stress.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence oxidative-stress regulation and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a human clinical study. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 10 patients with chronic lung diseases due to COPD (n = 7). The reported sample size was 10. The study used a human clinical study. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen concentration was 8 mM H₂ (≈16.1 mg/L). The reported treatment duration was 4 weeks.
Limitations and Safety
Reported limitations: There is a limitation in the ability of current medical therapies to reverse severe respiratory failure in COPD patients. Safety information: The biological safety of H₂ has been demonstrated in numerous studies dating back to the 1940s where molecular hydrogen was used to prevent decompression sickness in deep-sea diving [ 6 ].
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.